DRDO’s 2DG drug approved for emergency use as an adjunct therapy for COVID-19 patients - Job Community

Tuesday, 1 June 2021

Home Current Affairs Jagran Josh DRDO’s 2DG drug approved for emergency use as an adjunct therapy for COVID-19 patients

DRDO’s 2DG drug approved for emergency use as an adjunct therapy for COVID-19 patients

Md Wasim Abbas 05:56 Current Affairs, Jagran Josh,

The DRDO has informed that anti-COVID drug 2DG can now be given to the COVID-19 patients under the care and prescription of the doctors.

from Jagran Josh https://ift.tt/3fBulD0

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Created By Wasim Abbas | Distributed By Job Community